Metraipolis › archive › dc_43efd47bb0e4
Recurrent hypofibrinogenemia after reduced-dose tocilizumab rechallenge in rheumatoid arthritis: a case report — Europe PMC PMID:42973881
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42973881
- DOI
- 10.3389/fphar.2026.1981054
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T17:05:18.540Z
- SHA-256 of the archived text
eb6cb1cb6db1bc44a4aedb9fd418d26d3b2a904a9eeaf8a78c8adaa5f3900777- Stable URL of this page
https://metraipolis.com/documento/dc_43efd47bb0e4
How to cite
Recurrent hypofibrinogenemia after reduced-dose tocilizumab rechallenge in rheumatoid arthritis: a case report — Europe PMC PMID:42973881 — Europe PMC (en), https://europepmc.org/article/MED/42973881 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43efd47bb0e4 (Metraipolis archive dc_43efd47bb0e4, sha256 eb6cb1cb6db1bc44a4aedb9fd418d26d3b2a904a9eeaf8a78c8adaa5f3900777)
BibTeX
@misc{dc43efd47bb0e4,
title = {Recurrent hypofibrinogenemia after reduced-dose tocilizumab rechallenge in rheumatoid arthritis: a case report — Europe PMC PMID:42973881},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42973881},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43efd47bb0e4; sha256 eb6cb1cb6db1bc44a4aedb9fd418d26d3b2a904a9eeaf8a78c8adaa5f3900777},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42973881. Agents can read the archived copy with the MCP tool read_document.